Cargando…

Low-Molecular-Weight Heparin Enhanced Therapeutic Effects of Human Adipose-Derived Stem Cell Administration in a Mouse Model of Lupus Nephritis

BACKGROUND: Lupus nephritis is a life-threatening complication in systemic lupus erythematosus (SLE), but the efficiency of current therapies involving corticosteroids, immunosuppressants, and biological agents is limited. Adipose-derived mesenchymal stem cells (ASCs) are gaining attention as a nove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsuda, Shogo, Kotani, Takuya, Saito, Takashi, Suzuka, Takayasu, Mori, Tatsuhiko, Takeuchi, Tohru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8792143/ https://www.ncbi.nlm.nih.gov/pubmed/35095868 http://dx.doi.org/10.3389/fimmu.2021.792739

Ejemplares similares

Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
por: Suzuka, Takayasu, et al.
Publicado: (2022)

Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
por: Matsuda, Shogo, et al.
Publicado: (2023)

Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia
por: Kotani, Takuya, et al.
Publicado: (2017)

Publisher Correction: Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia
por: Kotani, Takuya, et al.
Publicado: (2018)

Publisher Correction: Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia
por: Kotani, Takuya, et al.
Publicado: (2018)

Human MIKO-1, a Hybrid Protein That Regulates Macrophage Function, Suppresses Lung Fibrosis in a Mouse Model of Bleomycin-Induced Interstitial Lung Disease
por: Kotani, Takuya, et al.
Publicado: (2022)

Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report
por: Matsuda, Shogo, et al.
Publicado: (2022)

Comment on: Combination of immunosuppressive therapy and nintedanib improves capillaroscopic changes in systemic sclerosis-interstitial lung disease: a case report. Reply
por: Matsuda, Shogo, et al.
Publicado: (2022)

Antifibrotic therapy by sustained release of low molecular weight heparin from poly(lactic-co-glycolic acid) microparticles on bleomycin-induced pulmonary fibrosis in mice
por: Saito, Takashi, et al.
Publicado: (2020)

Novel Autoantigens Associated with Lupus Nephritis
por: Onishi, Sachiko, et al.
Publicado: (2015)

Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease
por: Matsuda, Shogo, et al.
Publicado: (2021)

The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease
por: Wakura, Reiko, et al.
Publicado: (2020)

Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice
por: Uchida, Takahiro, et al.
Publicado: (2018)

The Role of Cytokine in the Lupus Nephritis
por: Iwata, Yasunori, et al.
Publicado: (2011)

Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
por: Reddy, Padmalatha S, et al.
Publicado: (2008)

Hydroxychloroquine administration exacerbates acute kidney injury complicated by lupus nephritis
por: An, Ning, et al.
Publicado: (2022)

The Pathogenesis of Lupus Nephritis
por: Sterner, Rosalie M., et al.
Publicado: (2014)

Pediatric lupus nephritis
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2018)

Hyperhomocysteinemia and Lupus Nephritis
por: Timlin, Homa, et al.
Publicado: (2019)

Management of Lupus Nephritis
por: Tamirou, Farah, et al.
Publicado: (2021)

Lupus Nephritis and Dysbiosis
por: Monticolo, Marta, et al.
Publicado: (2023)

Correction: Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
por: Reddy, Padmalatha S, et al.
Publicado: (2009)

Association between Serum Biomarkers and Peripheral Neuropathy in Microscopic Polyangiitis
por: Masuda, Yuichi, et al.
Publicado: (2022)

Non-histologic factors discriminating proliferative lupus nephritis from membranous lupus nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Kidney disease in lupus is not always 'lupus nephritis'
por: Anders, Hans-Joachim, et al.
Publicado: (2013)

Parasites alter the pathological phenotype of lupus nephritis
por: Miyake, Katsuhisa, et al.
Publicado: (2014)

Lupus nephritis: current update
por: Saxena, Ramesh, et al.
Publicado: (2011)

Chapter 12: Lupus nephritis
Publicado: (2012)

Biomarker Profiling for Lupus Nephritis
por: Li, Yajuan, et al.
Publicado: (2013)

The Role of Autophagy in Lupus Nephritis
por: Wang, Linlin, et al.
Publicado: (2015)

Current status of lupus nephritis
por: Jaryal, Ajay, et al.
Publicado: (2017)

Antiphospholipid Antibodies in Lupus Nephritis
por: Parodis, Ioannis, et al.
Publicado: (2016)

Urinary biomarkers in lupus nephritis
por: Aragón, Cristian C., et al.
Publicado: (2020)

Podocyte Injury in Lupus Nephritis
por: Sakhi, Hamza, et al.
Publicado: (2019)

Coccidioidomycosis in adolescents with lupus nephritis
por: Yorgin, Peter D., et al.
Publicado: (2001)

Individualizing Therapy in Lupus Nephritis
por: An, Yu, et al.
Publicado: (2019)

Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021)

Renal Fibrosis in Lupus Nephritis
por: Sciascia, Savino, et al.
Publicado: (2022)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
por: Schwartzman-Morris, Julie, et al.
Publicado: (2012)

Terbinafine Induced Lupus Erythematosus With Progression to Lupus Nephritis
por: Hindosh, Naif, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tp3kln95qdq0hr7o5cbf7kv45q